152 related articles for article (PubMed ID: 9751526)
21. Cloning of the human sodium lodide symporter.
Smanik PA; Liu Q; Furminger TL; Ryu K; Xing S; Mazzaferri EL; Jhiang SM
Biochem Biophys Res Commun; 1996 Sep; 226(2):339-45. PubMed ID: 8806637
[TBL] [Abstract][Full Text] [Related]
22. Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50.
Venkataraman GM; Yatin M; Ain KB
Thyroid; 1998 Jan; 8(1):63-9. PubMed ID: 9492156
[TBL] [Abstract][Full Text] [Related]
23. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
Tonacchera M; Agretti P; Ceccarini G; Lenza R; Refetoff S; Santini F; Pinchera A; Chiovato L; Vitti P
Eur J Endocrinol; 2001 Jun; 144(6):611-8. PubMed ID: 11375795
[TBL] [Abstract][Full Text] [Related]
25. Human sodium iodide symporter (hNIS) in fibroadenoma breast--a immunohistochemical study.
Rai R; Shrivastava A; Tandon A; Godbole MM; Kumar S; Das V; Dwivedi V; Pal L
Indian J Exp Biol; 2011 Feb; 49(2):113-7. PubMed ID: 21428212
[TBL] [Abstract][Full Text] [Related]
26. hNIS protein in thyroid: the iodine supply influences its expression and localization.
Scipioni A; Ferretti E; Soda G; Tosi E; Bruno R; Costante G; Meringolo D; Arturi F; Durante C; Amorosi A; Foschini MP; Nardi F; Russo D; Filetti S
Thyroid; 2007 Jul; 17(7):613-8. PubMed ID: 17696829
[TBL] [Abstract][Full Text] [Related]
27. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
[TBL] [Abstract][Full Text] [Related]
28. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.
Pohlenz J; Duprez L; Weiss RE; Vassart G; Refetoff S; Costagliola S
J Clin Endocrinol Metab; 2000 Jul; 85(7):2366-9. PubMed ID: 10902780
[TBL] [Abstract][Full Text] [Related]
29. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
Ryu KY; Senokozlieff ME; Smanik PA; Wong MG; Siperstein AE; Duh QY; Clark OH; Mazzaferri EL; Jhiang SM
Thyroid; 1999 Apr; 9(4):405-9. PubMed ID: 10319949
[TBL] [Abstract][Full Text] [Related]
30. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
[TBL] [Abstract][Full Text] [Related]
32. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
Trouttet-Masson S; Selmi-Ruby S; Bernier-Valentin F; Porra V; Berger-Dutrieux N; Decaussin M; Peix JL; Perrin A; Bournaud C; Orgiazzi J; Borson-Chazot F; Franc B; Rousset B
Am J Pathol; 2004 Jul; 165(1):25-34. PubMed ID: 15215159
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
[TBL] [Abstract][Full Text] [Related]
34. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.
Liou MJ; Lin JD; Chan EC; Liu FH; Chao TC; Weng HF
Cancer Lett; 2000 Nov; 160(1):75-80. PubMed ID: 11098087
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
36. Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter.
Lin X; Fischer AH; Ryu KY; Cho JY; Sferra TJ; Kloos RT; Mazzaferri EL; Jhiang SM
J Clin Endocrinol Metab; 2004 May; 89(5):2344-50. PubMed ID: 15126562
[TBL] [Abstract][Full Text] [Related]
37. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
38. Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues.
Lacroix L; Mian C; Caillou B; Talbot M; Filetti S; Schlumberger M; Bidart JM
Eur J Endocrinol; 2001 Mar; 144(3):297-302. PubMed ID: 11248751
[TBL] [Abstract][Full Text] [Related]
39. Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter.
Zhang Z; Liu YY; Jhiang SM
J Clin Endocrinol Metab; 2005 Nov; 90(11):6131-40. PubMed ID: 16105966
[TBL] [Abstract][Full Text] [Related]
40. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
